Englander Institute for Precision Medicine
Dr. Bishoy Faltas. Credit: Travis Curry

I am excited to announce Dr. Bishoy M. Faltas has been named Chief Research Officer of the Englander Institute for Precision Medicine (EIPM), effective immediately.

In this new capacity, Dr. Faltas will oversee EIPM's strategic research directions, and develop new programs and partnerships that integrate biology, technology, and...

Dr. Pashtoon Kasi

Historically, immunotherapy has demonstrated limited effectiveness in a significant majority of patients with colorectal cancer. However, promising findings from an investigator-initiated trial conducted at...

Imaging Mass Cytometry shows the immune-inflamed subtype of upper tract urothelial carcinoma at single-cell resolution. Red: tumor-expressed E-cadherin; Green: T-cell-expressed CD3; Blue: DNA. Credit: Hiranmayi Ravichandran, André Figueiredo Rendeiro and Kentaro Ohara.

Researchers at Weill Cornell Medicine have performed the most comprehensive analysis to date of cancer of the ureters or the urine-collection cavities in the kidney, known as upper tract urothelial carcinoma (UTUC).  The study, which compared the characteristics of primary and metastatic tumors, provides new insights into the biology of these aggressive cancers...